ATE423785T1 - Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c - Google Patents

Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c

Info

Publication number
ATE423785T1
ATE423785T1 AT03714097T AT03714097T ATE423785T1 AT E423785 T1 ATE423785 T1 AT E423785T1 AT 03714097 T AT03714097 T AT 03714097T AT 03714097 T AT03714097 T AT 03714097T AT E423785 T1 ATE423785 T1 AT E423785T1
Authority
AT
Austria
Prior art keywords
characterization
compositions
identification
methods
hcv
Prior art date
Application number
AT03714097T
Other languages
English (en)
Inventor
Carol Holland-Staley
Original Assignee
Lab 21 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab 21 Ltd filed Critical Lab 21 Ltd
Application granted granted Critical
Publication of ATE423785T1 publication Critical patent/ATE423785T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT03714097T 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c ATE423785T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36360302P 2002-03-11 2002-03-11

Publications (1)

Publication Number Publication Date
ATE423785T1 true ATE423785T1 (de) 2009-03-15

Family

ID=28041784

Family Applications (3)

Application Number Title Priority Date Filing Date
AT08014584T ATE469162T1 (de) 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c
AT08000552T ATE556084T1 (de) 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c
AT03714097T ATE423785T1 (de) 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT08014584T ATE469162T1 (de) 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c
AT08000552T ATE556084T1 (de) 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c

Country Status (9)

Country Link
US (3) US20070172926A1 (de)
EP (3) EP1490383B1 (de)
AT (3) ATE469162T1 (de)
AU (2) AU2003218111B8 (de)
DE (2) DE60326327D1 (de)
DK (3) DK1490383T3 (de)
ES (3) ES2386742T3 (de)
PT (3) PT1490383E (de)
WO (1) WO2003077729A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1490383E (pt) 2002-03-11 2009-05-25 Lab 21 Ltd Métodos e composições para identificar e caracterizar a hepatite c
US20090081636A1 (en) * 2005-04-11 2009-03-26 Mingjun Huang Pharmaceutical compositions for and methods of inhibiting HCV replication
WO2007042827A2 (en) * 2005-10-14 2007-04-19 Ivan Petyaev Treatment and diagnosis of obligate intracellular pathogens
CN100365124C (zh) * 2005-10-27 2008-01-30 云南大学 一段丙型肝炎病毒特异性cDNA序列的应用
US20080015787A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for treating disease
US20080015835A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for treating disease
US20090082344A1 (en) * 2006-07-13 2009-03-26 Searete Llc Methods and systems for treating disease
US20090325145A1 (en) 2006-10-20 2009-12-31 Erwin Sablon Methodology for analysis of sequence variations within the hcv ns5b genomic region
EP2121991A2 (de) 2006-10-20 2009-11-25 Innogenetics N.V. Methodik zur analyse von sequenzvariationen innerhalb des hcv-ns3/4a-genombereichs
CN101842498A (zh) * 2007-10-30 2010-09-22 英特芒尼公司 Hcv基因型分型和表型分型
RS51849B (en) * 2007-10-31 2012-02-29 Debiopharm S.A. EXAMINATION OF A SOON FULL GENOMA RESISTANCE TO HCV DRUG
US20130244936A1 (en) 2010-06-04 2013-09-19 Vincent Goffin Constitutively active prolactin receptor variants as prognostic markers and therapeutic targets to prevent progression of hormone-dependent cancers towards hormone-independence
US9528163B2 (en) 2011-06-20 2016-12-27 Siemens Healthcare Diagnostics Inc. Reagents and methods for detecting HCV
AU2013205064B2 (en) * 2012-06-04 2015-07-30 Gen-Probe Incorporated Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
JPH02500880A (ja) 1987-11-18 1990-03-29 カイロン　コーポレイション Ｎａｎｂｖの診断用薬およびワクチン
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
EP0435229A1 (de) * 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNS-Gen von einem Non-A Non-B Hepatitis-Virus, seine Klonierung und Verwendung
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
ES2188583T3 (es) * 1991-06-24 2003-07-01 Chiron Corp Polipeptidos para el virus de la hepatitis c (hcv).
US20030125270A1 (en) * 2000-12-18 2003-07-03 Lawrence Blatt Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection
CA2139100C (en) * 1993-04-27 2009-06-23 Geert Maertens New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
ES2231773T3 (es) * 1993-05-05 2005-05-16 Common Services Agency Virus de la hepatitis c de tipo 4, 5 y 6.
US5571673A (en) * 1994-11-23 1996-11-05 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US7338759B1 (en) * 1997-03-04 2008-03-04 Washington University HCV variants
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
KR20010022420A (ko) * 1997-07-30 2001-03-15 추후제출 항 바이러스성 약품의 민감성과 내성의 결정 및 항바이러스성 약품의 스크리닝을 위한 조성물 및 방법
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
ATE404698T1 (de) * 2000-04-18 2008-08-15 Virco Bvba Methode zur bestimmung der resistenz gegen medikamente
EP1296998B1 (de) * 2000-05-23 2011-09-21 Washington University Varianten des hepatitisvirus
EP1373576A4 (de) * 2000-07-24 2005-06-15 Inst Of Molecul & Cell Biology Nukleinsäuren und verfahren zum nachweis viraler infektionen, aufspüren von anti-viralen verbindungen und bestimmiung der medikamentenresistenz von virusisolaten
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
PT1490383E (pt) 2002-03-11 2009-05-25 Lab 21 Ltd Métodos e composições para identificar e caracterizar a hepatite c

Also Published As

Publication number Publication date
DK1490383T3 (da) 2009-06-08
AU2003218111B2 (en) 2008-11-06
ATE469162T1 (de) 2010-06-15
AU2003218111B8 (en) 2008-11-20
AU2008249300B2 (en) 2012-08-16
EP1490383A4 (de) 2005-12-21
EP1947104A2 (de) 2008-07-23
ES2321498T3 (es) 2009-06-08
DK2014671T3 (da) 2010-09-20
WO2003077729A2 (en) 2003-09-25
AU2003218111A1 (en) 2003-09-29
EP1490383A2 (de) 2004-12-29
US20090047663A1 (en) 2009-02-19
DK1947104T3 (da) 2012-08-06
ATE556084T1 (de) 2012-05-15
US8173795B2 (en) 2012-05-08
US20070172926A1 (en) 2007-07-26
WO2003077729A9 (en) 2004-04-22
PT1490383E (pt) 2009-05-25
EP2014671A1 (de) 2009-01-14
EP1947104A3 (de) 2009-04-08
EP1490383B1 (de) 2009-02-25
DE60326327D1 (de) 2009-04-09
WO2003077729A3 (en) 2004-06-03
PT1947104E (pt) 2012-08-09
PT2014671E (pt) 2010-06-16
AU2008249300A1 (en) 2008-12-18
EP1947104B1 (de) 2012-05-02
US20120322051A1 (en) 2012-12-20
ES2386742T3 (es) 2012-08-28
EP2014671B1 (de) 2010-05-26
ES2346717T3 (es) 2010-10-19
DE60332781D1 (de) 2010-07-08

Similar Documents

Publication Publication Date Title
ATE423785T1 (de) Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c
ATE432365T1 (de) Verfahren, kits und reagenzien zur nukleinsäuresequenzierung
DE60041940D1 (de) Oligonukleotidprimer zur effizienten Detektion von Hepatitis C Virus (HCV) sowie Verwendungsverfahren
DE60039037D1 (de) Methode zur direkten sequenzierung von nukleinsäuren
ATE257861T1 (de) Methoden und zusammensetzungen zur effizienten nukleinsaeuresequenzierung
HK1074458A1 (en) Thermostable taq polymerase fragment
ATE364718T1 (de) Verfahren zur vervielfältigung von nukleinsäure
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
DE60132924D1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
ATE516365T1 (de) Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer
DE602005023586D1 (de) Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv
DE60024679D1 (de) Methoden und zusammensetzungen zur detektion von spezies des mycobacterium avium-komplexes
DE60015210D1 (de) Oligonukleotid Primer zur effizienten reversen Transkription von Hepatitis C Virus (HCV) RNS und Verfahren zu deren Verwendung
ATE486932T1 (de) Thermostabile dna polymerase von archae ampullavirus abv und dessen verwendungen
DE59912683D1 (de) Verfahren und Zusammensetzungen zur Isolierung und Reinigung von Nukleinsäuren
ATE328117T1 (de) Verfahren und sonden zur genetischen diagnose von heriditärer hämochromatose
ATE414175T1 (de) Detektion von rpob sequenzen von mycobacterium tuberculosis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1490383

Country of ref document: EP